GEIPE Answers to the Questions
That FTC and FDA Want Cancer Patients To Ask

American Federal Trade Commission (FTC) works with Food & Drug Administration (FDA) and wants patients to ask certain questions before deciding whether to purchase a health-related product or therapy:

Those questions along with answers of Non-Invasive GEIPE treatment are provided below:

Question 1. What is in the product; what does this therapy entail?

Answer: The GEIPE cancer treatment involves low-level direct current electrotherapy. We provide the device and instructions. Patients to buy appropriate conducting electrodes from a third-party vendor. Non-invasive form of GEIPE is almost like a home remedy and needs to be applied for 6 to 8 hrs per day for 8-12 weeks, on average.

Question 2. What is the evidence that this product/therapy will do whatever the product/therapy purports to do (e.g., counteract the disease or medical condition being treated; relieve symptoms or side effects; lead to better results than conventional treatment)? 

Answer: “Scientific Articles” page of this web site has a link to the 4-page primary article which documents 10 scientific studies, 3 of which had very positive results with gentle electrotherapy. (Other 7 studies used parameters outside the GEIPE therapy range.) Nine of these studies were done with animals and one with humans. The same page also has links to selected section of the article which reported 98% reduction in tumor mass in 5 hr. treatment over 5 days. “The Struggle” page of the web site gives reason why cancer institutions have not taken initiative to do clinical trials with human. Please also read “Cancer Cure?” page of the web site.

It is noteworthy that “high-level” electrotherapy called Nordenstrom Modality is quite popular among poor cancer patients in China. Due to the toxic electrochemistry involved in that treatment, only a few applications are given. GEIPE treatment on the other hand is non-toxic, is known to have higher efficacy and can be applied repeatedly.

Question 3. Have results from studies of this product/therapy been published in any peer-reviewed medical journals? Can I have copies of the publications or references to these publications?

Answer: Yes. Please see answer to the previous question. The link to the ‘primary’ article on the “Scientific Articles” page of the web site has the entire article. You can also go to any bio-med library to see this article. There you should also look at the reference #4, #5 and #7 cited in this article.

Question 4. How will I know that the product/therapy is or is not working?

Answer: After 3-4 weeks of GEIPE therapy, you should notice arrest of further growth of tumor and attendant relief.

Question 5. What is the evidence that the product/therapy is safe? Are there potential side effects?

Answer: Direct Current electricity at such low-levels is deemed to be safe. For example, most major manufacturers of electrotherapy electrodes include an advisory with their electrodes that patients should not exceed 0.1 watts/cm². Current and voltage levels employed with GEIPE treatment will generate about one-hundredths (1/100^th) of this limit.

We are not aware of any potential side effects. If patients notice some adverse reaction that correlates with GEIPE treatment, they should immediately stop the treatment and inform us of the circumstances.

Question 6. Are there potential interactions with prescription medications?

Answer: We are not aware of any. No studies have been done in this area.

Question 7. What are the training and credentials of the provider?

Answer: Please see “About Us” page of the web site.

Question 8. Is the provider willing to communicate with my primary care physician and/or my health insurance company? 

Answer: Yes.

ŠŠŠ